Powerus receives $82 million U.S. government order for counter-drone systems
Bitget2026/10/06 13:06Powerus received an order worth $82 million for counter-unmanned aerial systems under an existing U.S. government IDIQ contract. Marks the second order under the contract; deliveries expected over the next several quarters. Order includes support equipment, operator training, field service representative support; additional orders may follow at the customer’s discretion. Systems will be built in the U.S. using NDAA-compliant components. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Powerus Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610060905PRIMZONEFULLFEED9840475) on October 06, 2026, and is solely responsible for the information contained therein.
- Powerus received an order worth $82 million for counter-unmanned aerial systems under an existing U.S. government IDIQ contract.
- Marks the second order under the contract; deliveries expected over the next several quarters.
- Order includes support equipment, operator training, field service representative support; additional orders may follow at the customer’s discretion.
- Systems will be built in the U.S. using NDAA-compliant components.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Chip design software leader Synopsys seeks collaboration with Chinese large model laboratories

Former BioNTech executive leads Bambusa Therapeutics (BBTX.US) in sprint to Nasdaq, "boosting" eczema drug trials
Bambusa Therapeutics Inc. has filed for an initial public offering, planning to raise funds for clinical trials of treatments for eczema and other inflammatory diseases.